semaglutide flyer For all our Medicare folks 👋 — this upcoming GLP-1 Bridge Program may help make select weight-loss medications more affordable starting July 2026. 💉✨ We're very happy to announce

One further nuance worth noting: the addition of GIP in both tirzepatide and retatrutide is hypothesised to improve gastrointestinal tolerability relative to GLP-1 alone at comparable efficacy

Licenses and registrations like this mean the facilities can be inspected and need to comply with safety and quality standards

On phentermine, the stimulant effect may actually increase exercise capacity and motivation, though patients should monitor heart rate carefully during workouts

Keith King To view or add a comment, sign in A New Era in Treating Metabolic Liver Disease For years, clinicians could only counsel lifestyle modification for patients with Metabolic dysfunctionassociated steatotic liver disease (MASLD) and Metabolic dysfunctionassociated steatohepatitis (MASH)